HIV drug could be made for just $40 a year for every patient
Generic version of a drug already on the market, which can suppress and prevent HIV, would still yield 30% profit if the current price was slashed, researchers say
My embarrassing condition needs a simple operation – but in Nigeria few can afford it
Michael Adebisi
Gynecomastia – the benign growth of male breast tissue – is easily fixed but at a prohibitive cost for most Nigerians, leading many men to experience stigma and poor mental health
Cost of developing new drugs may be far lower than industry claims, trial reveals
Exclusive: MSF calls for transparency after its bill for a trial of TB treatment came to a fraction of the billions claimed by pharmaceutical companies
Kenya’s ‘blood desert’: can walking donor banks and drones help more patients survive?
The national blood deficit is most pressing in places like Turkana, where malaria, anaemia and violence make heavy demands on transfusion services – and doctors are pinning their hopes on innovation
‘I wish I’d had someone like me to talk to’: the mothers helping fight cervical cancer in Malawi
The country has one of the world’s highest death rates from the disease but a campaign led by young mothers is ensuring girls have access to the HPV vaccine
